These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1430 related items for PubMed ID: 26655607
1. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis. Heimes B, Farecki ML, Bartels S, Barrelmann A, Gutfleisch M, Spital G, Lommatzsch A, Pauleikhoff D. Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607 [Abstract] [Full Text] [Related]
2. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study. Clemens CR, Wolf A, Alten F, Milojcic C, Heiduschka P, Eter N. Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038 [Abstract] [Full Text] [Related]
3. RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Cho HJ, Kim HS, Yoo SG, Han JI, Lew YJ, Cho SW, Lee TG, Kim JW. Retina; 2016 Oct; 36(10):1851-9. PubMed ID: 27074658 [Abstract] [Full Text] [Related]
5. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography. Nagiel A, Freund KB, Spaide RF, Munch IC, Larsen M, Sarraf D. Am J Ophthalmol; 2013 Nov; 156(5):981-988.e2. PubMed ID: 23972309 [Abstract] [Full Text] [Related]
6. Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence. Introini U, Torres Gimeno A, Scotti F, Setaccioli M, Giatsidis S, Bandello F. Graefes Arch Clin Exp Ophthalmol; 2012 Sep; 250(9):1283-92. PubMed ID: 22350060 [Abstract] [Full Text] [Related]
7. Repair mechanism of retinal pigment epithelial tears in age-related macular degeneration. Mukai R, Sato T, Kishi S. Retina; 2015 Mar; 35(3):473-80. PubMed ID: 25207945 [Abstract] [Full Text] [Related]
8. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration. Shin JY, Choi M, Chung B, Byeon SH. Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2151-60. PubMed ID: 25744335 [Abstract] [Full Text] [Related]
9. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Dolz-Marco R, Phasukkijwatana N, Sarraf D, Freund KB. Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752 [Abstract] [Full Text] [Related]
10. Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment. Clemens CR, Bastian N, Alten F, Milojcic C, Heiduschka P, Eter N. Acta Ophthalmol; 2014 Feb; 92(1):e50-6. PubMed ID: 23819839 [Abstract] [Full Text] [Related]
11. SPATIAL PATTERN OF RETINAL PIGMENT EPITHELIUM TEAR DEVELOPMENT AND PROGRESSION AFTER ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Fukui T, Ishikawa K, Shiose S, Kano K, Mori K, Notomi S, Sonoda KH. Retin Cases Brief Rep; 2024 May 01; 18(3):371-377. PubMed ID: 36730109 [Abstract] [Full Text] [Related]
12. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Vazquez-Alfageme C, Nicholson L, Hamilton RD, Patel PJ. Retina; 2019 Apr 01; 39(4):664-669. PubMed ID: 29324593 [Abstract] [Full Text] [Related]
14. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT, Lin SG, Rauser ME, Kaiser PK. Retina; 2007 Jun 01; 27(5):541-51. PubMed ID: 17558314 [Abstract] [Full Text] [Related]
15. Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretion. Hoerster R, Muether PS, Sitnilska V, Kirchhof B, Fauser S. Retina; 2014 Sep 01; 34(9):1767-73. PubMed ID: 24936942 [Abstract] [Full Text] [Related]
16. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials. Sharma S, Toth CA, Daniel E, Grunwald JE, Maguire MG, Ying GS, Huang J, Martin DF, Jaffe GJ, Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Ophthalmology; 2016 Apr 01; 123(4):865-75. PubMed ID: 26783095 [Abstract] [Full Text] [Related]
17. Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography. Inoue M, Arakawa A, Yamane S, Kadonosono K. Br J Ophthalmol; 2014 Jul 01; 98(7):956-60. PubMed ID: 24599418 [Abstract] [Full Text] [Related]
18. Anatomical and visual outcomes of ranibizumab injections in retinal pigment epithelium tears. Erol MK, Ozdemir O, Coban DT, Ceran BB, Sari ES. Arq Bras Oftalmol; 2015 Jul 01; 78(3):168-72. PubMed ID: 26222106 [Abstract] [Full Text] [Related]
19. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections. Chan CK, Abraham P, Meyer CH, Kokame GT, Kaiser PK, Rauser ME, Gross JG, Nuthi AS, Lin SG, Daher NS. Retina; 2010 Feb 01; 30(2):203-11. PubMed ID: 19952998 [Abstract] [Full Text] [Related]
20. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration]. Bidot ML, Malvitte L, Bidot S, Bron A, Creuzot-Garcher C. J Fr Ophtalmol; 2011 Jun 01; 34(6):376-81. PubMed ID: 21550687 [Abstract] [Full Text] [Related] Page: [Next] [New Search]